Sector Alpha Week of 2026-07-31
Sector Alpha — machine-written from the numbers · Data as of 2026-07-31

Exato Technologies Ltd

544626
IT - Software

Exato Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work.

The price is in a confirmed uptrend (33 weeks in) while the P/E sits at the 98th percentile of its own 1-year range. Underneath, the last four quarters read deteriorating — profit −24.2% year on year, and 3% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
₹586
P/E
36.6×
98th pctile
of its own 1-year range
Revenue (Mar 26)
₹61.1 Cr
+4.0% YoY
Profit (Mar 26)
₹4.2 Cr
−24.2% YoY
Operating margin
10.4%
−3.9 pp YoY
ROCE
27%
FY26
Cash conversion
3%
of profit, last 3 FY
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Exato Technologies Ltd trades at ₹586, in a confirmed uptrend and 33 weeks into that stage. That is +54.9% against its own 200-day average. It sits at 100% of a 52-week range of ₹354 to ₹586. On relative strength it has no relative-strength read yet.

Today the stock is in a confirmed uptrend — week 33 of stage 2, confirmed. At ₹586 it trades +54.9% versus its 200-day average and sits at 100% of its 52-week range (₹354–₹586).

Jul 26: ₹586 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
+54.9% versus the 200-day line, week 33 of stage 2
Price50-day avg200-day avg
S2₹606₹533₹459₹386₹313₹586₹378May 26Jun 26Jun 26Jul 26Jul 26
S2₹606₹533₹459₹386₹313₹586₹378May 26Jun 26Jul 26

Against the market, two honest reads. Cumulative: over the last 2 months the stock moved +65% while the NIFTY 500 moved +4% — ahead of the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Exato Technologies Ltd trades at 36.6× P/E, about the priciest it has ever traded. Its long-run median P/E is 0.1×, measured across 0.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 36.6× is about the priciest it has ever traded, against a long-run median of 0.1× measured over 0.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 36.6× vs a 0.1× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 0.6-year window; loss-period spikes above 0.3× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
about the priciest it has ever traded
P/EMedianEPS (TTM) (quarterly)
0.32×₹3,8780.26×₹2,9090.20×₹1,9390.14×₹9700.08×₹0.0×0.30×₹16Dec 25Feb 26Apr 26Jun 26Jul 26
0.32×₹3,8780.26×₹2,9090.20×₹1,9390.14×₹9700.08×₹0.0×0.30×₹16Dec 25Apr 26Jul 26
P/E
36.6×
98th percentile of 1y

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Exato Technologies Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read.

Growth, year by year: revenue +35.5% in FY26, profit +60.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
60%116%46%58%33%0.0%19%−58%5.0%−116%%%35.5%60%FY23FY24FY26
60%116%46%58%33%0.0%19%−58%5.0%−116%%%35.5%60%FY23FY24FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfit
24%96%18%64%13%31%7.8%0.0%2.5%−33%%%4%−24.2%Dec 24Sep 25Mar 26
24%96%18%64%13%31%7.8%0.0%2.5%−33%%%4%−24.2%Dec 24Sep 25Mar 26
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
27.2%26.6%26.0%25.4%24.8%%27%FY24FY25FY26
27.2%26.6%26.0%25.4%24.8%%27%FY24FY25FY26
ROCE
Steady high
latest 27.0% · span 25.0%–27.0%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+35.5%+32.0%
Profit+60.0%+47.4%
EPS−99.8%−84.2%
Revenue YoY (Mar 26)
+4.0%
latest quarter vs a year ago
Profit YoY (Mar 26)
−24.2%
latest quarter vs a year ago
Revenue 10y
32.0%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

52.7/100 — rank 55 of 63 in IT - Software · 33% evidence confidence · provisional, ranked below fully-evidenced peers

Exato Technologies Ltd scores 52.7 out of 100 against the 63 companies it is compared with in IT - Software, ranking 55. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 17.1 + 16.1 + 9.5 + 10 = 52.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Exato Technologies Ltd reported ₹61.1 Cr of revenue in the Mar 26 quarter, +4.0% year on year. That is the 2nd straight quarter of year-on-year growth. Over 3 years it has compounded at 32.0% a year. The last full year, FY26, came in at ₹168 Cr. The last four reported quarters add to ₹198 Cr.

FY26 revenue came in at ₹168 Cr (+35.5% on the year), capping 3 years at 32.0% compound. The latest quarter (Mar 26) printed ₹61.1 Cr, +4.0% year on year — the 2nd consecutive quarter of year-over-year growth.

FY26 revenue ₹168 Cr (+35.5% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 4-year window. A bar is red when it is lower than the year before.
32.0% a year over 3 years
RevenueYoY growth
18160%13646%9133%4519%05.0%₹ Cr%₹16835.5%FY23FY24FY26
18160%13646%9133%4519%05.0%₹ Cr%₹16835.5%FY23FY24FY26
Mar 26: ₹61.1 Cr (+4.0% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Revenue (quarterly)YoY growth
6624%4918%3313%167.8%02.5%₹ Cr%₹614%Dec 24Sep 25Mar 26
6624%4918%3313%167.8%02.5%₹ Cr%₹614%Dec 24Sep 25Mar 26

Pace check: the last four quarters averaged +13.2% growth against the decade's 32.0% — the current year is running slower than its own long-run rate.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Exato Technologies Ltd's operating margin is 10.4% in the Mar 26 quarter, −3.9 percentage points against the same quarter a year ago. Across the last four quarters the operating margin has moved −2.7 percentage points. Across 4 fiscal years the operating margin has ranged 7.0% to 14.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 10.4%, −3.9 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 7.0%–14.0%.

🚨 Why the margin moved: operating margin went −2.7 pp year on year while gross margin went −7.3 pp — the loss came mostly from the gross line: input costs and pricing.

FY26: 14.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 4-year window.
within a 7.0–14.0% band over 4 years
operating marginYoY change (pp)
15%4.4%13%3.0%11%1.5%8.5%0.0%6.4%−1.4%%%14%3%FY23FY24FY26
15%4.4%13%3.0%11%1.5%8.5%0.0%6.4%−1.4%%%14%3%FY23FY24FY26
Mar 26: 10.4% operating margin (−3.9 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
20%7.0%17%4.1%15%1.1%12%−1.8%9.7%−4.7%%%10.4%−3.9%Dec 24Sep 25Mar 26
20%7.0%17%4.1%15%1.1%12%−1.8%9.7%−4.7%%%10.4%−3.9%Dec 24Sep 25Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Exato Technologies Ltd earned ₹4.2 Cr of net profit in the Mar 26 quarter, −24.2% year on year. Full-year FY26 profit was ₹16.0 Cr. The 3-year compound rate is 47.4%. That is 6.9% of the quarter's revenue. The same quarter a year earlier earned ₹2.5 Cr.

Mar 26 profit was ₹4.2 Cr, −24.2% year on year. On the full year, FY26 printed ₹16.0 Cr (+60.0%), and the 3-year compound rate is 47.4%.

FY26 profit ₹16.0 Cr (+60.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 4-year window. A bar is red when it is lower than the year before.
47.4% a year over 3 years
Net profitYoY growth
17108%1379%950%421%0−8.0%₹ Cr%₹1660%FY23FY24FY26
17108%1379%950%421%0−8.0%₹ Cr%₹1660%FY23FY24FY26
Mar 26: ₹4.2 Cr (−24.2% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
696%564%331%20.0%0−33%₹ Cr%₹4−24.2%Dec 24Sep 25Mar 26
696%564%331%20.0%0−33%₹ Cr%₹4−24.2%Dec 24Sep 25Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 3% of Exato Technologies Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹2.0 Cr of operating cash against ₹16.0 Cr of profit. After ₹13.0 Cr of capital spending, ₹−11.0 Cr was left as free cash.

FY26: operating cash of ₹2.0 Cr against reported profit of ₹16.0 Cr, leaving free cash of ₹−11.0 Cr after ₹13.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 3% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹2.0 Cr vs profit ₹16.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 4-year window, annual resolution.
3% of 3-year profit arrived as cash
Operating cashNet profitFree cash
199−2−12−22₹ Cr₹2₹16₹−11FY23FY24FY26
199−2−12−22₹ Cr₹2₹16₹−11FY23FY24FY26
FY26: CFO = 13% of profit (three-year rate 3%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
238%99%−40%−179%−318%%13%FY23FY24FY26
238%99%−40%−179%−318%%13%FY23FY24FY26

🚨 Why conversion sits at 3%: the cash cycle stretched 65 days between FY23 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: conversion is below par and the cash cycle has stretched 65 days — the next section's job is to find where the cash is stuck.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Exato Technologies Ltd's cash conversion cycle runs 80 days in FY26, up from 15 days in FY23. Capital spending ran ₹32.0 Cr over the last 3 years. At FY26 sales of ₹168 Cr each day of that cycle holds about ₹0.5 Cr, so roughly ₹37.0 Cr sits inside the business at any moment.

FY26: debtors at 93 days, inventory at 11 days — roughly 0.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 80 days, looser than FY23's 15.

The full loop: cash goes out to suppliers and production on day 0; stock waits 11 days to sell; customers pay about 93 days after that; and suppliers themselves are paid at 24 days — netting out to the 80-day cycle.

In money terms: at FY26 sales of ₹168 Cr, each day of the cycle holds about ₹0.5 Cr — so the 80-day loop keeps roughly ₹37.0 Cr sitting inside the business at any moment.

FY26: a 80-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 4-year window.
+65 days vs FY23
Cash cycleInventory daysDebtor daysPayable days
1068054282days80d11d93d24dFY23FY24FY26
1068054282days80d11d93d24dFY23FY24FY26

On the investment side: capital spending of ₹32.0 Cr over the last 3 fiscal years against ₹2.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹13.0 Cr, work-in-progress ₹0.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
1713940₹ Cr₹13₹0FY24FY25FY26
1713940₹ Cr₹13₹0FY24FY25FY26

The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Exato Technologies Ltd earns a ROCE of 27% in FY26. That is up from a trough of 25% in FY24. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 9.5% net margin on 1.37× asset turns.

FY26 ROCE is 27%, recovered from a FY24 trough of 25% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 9.5% net margin × 1.37× asset turns × 1.40× balance-sheet leverage ≈ 18.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

FY26: ROCE 27% Return on capital employed by fiscal year, % (line). 3-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY24's 25%
ROCEWACC
28%24%20%15%11%%27%FY24FY25FY26
28%24%20%15%11%%27%FY24FY25FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.

Exato Technologies Ltd carries ₹21.0 Cr of borrowings against ₹88.0 Cr of equity in FY26, a debt-to-equity of 0.24. Operating profit covers the interest bill 12×. Over 3 years borrowings went from ₹6.0 Cr to ₹21.0 Cr. Capital spending ran ₹32.0 Cr across the last 3 of those years.

FY26: borrowings of ₹21.0 Cr against equity of ₹88.0 Cr — a debt-to-equity of 0.24. Operating profit covers the interest bill 12×. Over 3 years borrowings went from ₹6.0 Cr to ₹21.0 Cr while capital spending ran ₹32.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.

FY26: borrowings ₹21.0 Cr at 0.24× equity Borrowings by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 4-year window. Quarterly balance-sheet history is not held for India — annual is the honest resolution.
the debt trajectory
BorrowingsDebt-to-equity
350.8×260.7×170.5×90.3×00.2×₹ Cr×₹210.24×FY23FY24FY26
350.8×260.7×170.5×90.3×00.2×₹ Cr×₹210.24×FY23FY24FY26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Exato Technologies Ltd moved a full percentage point over the last two years — the register is quiet. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — .

A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 2 quarters.
PromotersForeign inst.Domestic inst.Public
59%43%27%11%−4.4%%54.7%0%7.9%37.4%Dec 25Mar 26
59%43%27%11%−4.4%%54.7%0%7.9%37.4%Dec 25Mar 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Exato Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · IT - Software
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Coforge LtdCOFORGE 75.9/100Favorable setup100% evidence BREAKING OUT 30.3/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence 15.6/25 ROCE 23.5% · OPM 19% 100% evidence 12.6/20 P/E 39.8× · PEG 0.57 100% evidence 17.4/20 RS sector 7.8% · RS bench 10.4% · 1Y 1.9%11 of 12 weeks ahead 100% evidence
Exact sum: 30.3 + 15.6 + 12.6 + 17.4 = 75.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Silver Touch Technologies LtdSILVERTUC 71.3/100Favorable setup93% evidence LEADER 30.6/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence 16.9/25 ROCE 28.9% · OPM 22% 100% evidence 10.2/20 P/E 61.4× · PEG 1.11 65% evidence 13.6/20 RS sector 54.7% · RS bench 61.9% · 1Y 157%12 of 12 weeks ahead 100% evidence
Exact sum: 30.6 + 16.9 + 10.2 + 13.6 = 71.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3NINtec Systems LtdNINSYS 70.8/100Favorable setup76% evidence LEADER 20.8/35 Revenue 21.7% · PAT 21.6% · OPM change 8.1 pp 83% evidence 21.9/25 ROCE 55% · OPM 30.1% 95% evidence 9.2/20 P/E 45.4× · PEG — 15% evidence 18.9/20 RS sector 53.9% · RS bench 58.6% · 1Y 84.9%12 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 21.9 + 9.2 + 18.9 = 70.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4InfoBeans Technologies LtdINFOBEAN 67.4/100Favorable setup81% evidence ASLEEP 27.0/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence 16.8/25 ROCE 29.2% · OPM 21% 95% evidence 9.5/20 P/E 19× · PEG — 50% evidence 14.1/20 RS sector 17.4% · RS bench -0.7% · 1Y 18.3%4 of 10 weeks ahead 70% evidence
Exact sum: 27 + 16.8 + 9.5 + 14.1 = 67.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
5Sasken Technologies LtdSASKEN 65.9/100Favorable setup100% evidence LEADER 30.8/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence 7.7/25 ROCE 9.9% · OPM 9% 100% evidence 9.6/20 P/E 37.3× · PEG 0.68 100% evidence 17.8/20 RS sector 15.4% · RS bench 19.1% · 1Y 23.3%12 of 12 weeks ahead 100% evidence
Exact sum: 30.8 + 7.7 + 9.6 + 17.8 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Sahana Systems LtdSAHANA 65.3/100Favorable setup70% evidence BASING 21.8/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 19.4/25 ROCE 39.8% · OPM 29% 95% evidence 14.4/20 P/E 13.2× · PEG — 50% evidence 9.7/20 RS sector -14.3% · RS bench 3.2% · 1Y -35.4%0 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 19.4 + 14.4 + 9.7 = 65.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Cigniti Technologies LtdCIGNITITEC 64.3/100Mixed-positive evidence79% evidence 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence 16.1/25 ROCE 34.1% · OPM 18% 75% evidence 16.1/20 P/E 11.4× · PEG 0.61 100% evidence 8.7/20 RS sector -9.5% · RS bench -15% · 1Y -20.5%0 of 1 week ahead to 2026-05-17 100% evidence
Exact sum: 23.4 + 16.1 + 16.1 + 8.7 = 64.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Hypersoft Technologies Ltd539724 63.2/100Mixed-positive evidence61% evidence LEADER 25.7/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence 12.0/25 ROCE 20.6% · OPM 14% 76% evidence 8.6/20 P/E 441× · PEG — 15% evidence 16.9/20 RS sector 81.1% · RS bench 88.7% · 1Y 282.1%12 of 12 weeks ahead 70% evidence
Exact sum: 25.7 + 12 + 8.6 + 16.9 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Tech Mahindra LtdTECHM 63.0/100Mixed-positive evidence94% evidence TURNING 20.8/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence 16.1/25 ROCE 23.1% · OPM 17% 100% evidence 10.8/20 P/E 30.4× · PEG 0.76 100% evidence 15.3/20 RS sector 14.8% · RS bench 9.3% · 1Y 13%4 of 11 weeks ahead 70% evidence
Exact sum: 20.8 + 16.1 + 10.8 + 15.3 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10ASM Technologies Ltd526433 62.9/100Mixed-positive evidence65% evidence TURNING 23.7/35 Revenue 82.1% · PAT 100% · OPM change -4 pp 83% evidence 15.5/25 ROCE 27% · OPM 18% 76% evidence 8.8/20 P/E 118× · PEG — 15% evidence 14.9/20 RS sector 5.7% · RS bench 43% · 1Y 61.1%10 of 10 weeks ahead 70% evidence
Exact sum: 23.7 + 15.5 + 8.8 + 14.9 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Saksoft LtdSAKSOFT 62.8/100Mixed-positive evidence90% evidence TURNING 24.0/35 Revenue 14% · PAT 22% · OPM change 3 pp 88% evidence 18.7/25 ROCE 25.5% · OPM 18% 100% evidence 13.5/20 P/E 16.4× · PEG 0.41 100% evidence 6.6/20 RS sector -21.2% · RS bench -3.3% · 1Y -21.8%6 of 11 weeks ahead 70% evidence
Exact sum: 24 + 18.7 + 13.5 + 6.6 = 62.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -21.2% and the one-year return is -21.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
12Softtech Engineers LtdSOFTTECH 61.2/100Mixed-positive evidence76% evidence FADING 27.8/35 Revenue 39.5% · PAT 100% · OPM change 6.2 pp 83% evidence 11.7/25 ROCE 6.2% · OPM 21.4% 95% evidence 8.8/20 P/E 117× · PEG — 15% evidence 12.9/20 RS sector 12.7% · RS bench 15.9% · 1Y 15.6%11 of 12 weeks ahead 100% evidence
Exact sum: 27.8 + 11.7 + 8.8 + 12.9 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Datamatics Global Services LtdDATAMATICS 60.9/100Mixed-positive evidence90% evidence TURNING 20.9/35 Revenue 15.3% · PAT -5.8% · OPM change 6 pp 88% evidence 17.9/25 ROCE 20.8% · OPM 21% 100% evidence 8.5/20 P/E 20.6× · PEG 1.08 100% evidence 13.6/20 RS sector 9.6% · RS bench 0.6% · 1Y -5.4%6 of 10 weeks ahead 70% evidence
Exact sum: 20.9 + 17.9 + 8.5 + 13.6 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14R Systems International LtdRSYSTEMS 60.4/100Mixed-positive evidence96% evidence BASING 23.9/35 Revenue 18.3% · PAT 48.3% · OPM change 2 pp 88% evidence 14.5/25 ROCE 19.5% · OPM 18% 100% evidence 18.2/20 P/E 13.5× · PEG 0.26 100% evidence 3.8/20 RS sector -26% · RS bench -24.4% · 1Y -37.4%0 of 12 weeks ahead 100% evidence
Exact sum: 23.9 + 14.5 + 18.2 + 3.8 = 60.4 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -26% and the one-year return is -37.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
15BLS E-Services LtdBLSE 58.2/100Mixed-positive evidence71% evidence LEADER 19.4/35 Revenue 100% · PAT 16.9% · OPM change -2 pp 83% evidence 10.5/25 ROCE 17% · OPM 6% 76% evidence 9.0/20 P/E 47.5× · PEG — 15% evidence 19.3/20 RS sector 47.6% · RS bench 51.9% · 1Y 62.6%12 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 10.5 + 9 + 19.3 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16String Metaverse Ltd534535 56.8/100Mixed-positive evidence78% evidence ASLEEP 26.3/35 Revenue 100% · PAT 100% · OPM change 0 pp 83% evidence 15.4/25 ROCE 41.6% · OPM 10% 76% evidence 14.7/20 P/E 6.8× · PEG — 50% evidence 0.4/20 RS sector -67.5% · RS bench -60.8% · 1Y -80.6%0 of 12 weeks ahead 100% evidence
Exact sum: 26.3 + 15.4 + 14.7 + 0.4 = 56.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -67.5% and the one-year return is -80.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
17Sonata Software LtdSONATSOFTW 56.7/100Mixed-positive evidence93% evidence BREAKING OUT 11.7/35 Revenue 5.4% · PAT 8.9% · OPM change 1 pp 83% evidence 16.8/25 ROCE 30.7% · OPM 8% 95% evidence 14.4/20 P/E 17.7× · PEG 0.61 100% evidence 13.8/20 RS sector -1.1% · RS bench 1.3% · 1Y -21.9%7 of 12 weeks ahead 100% evidence
Exact sum: 11.7 + 16.8 + 14.4 + 13.8 = 56.7 · Decision use: Price leads the evidence: RS versus the benchmark is 1.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
18Ksolves India LtdKSOLVES 56.6/100Mixed-positive evidence87% evidence ASLEEP 17.6/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence 20.3/25 ROCE 131% · OPM 30.3% 95% evidence 13.6/20 P/E 18× · PEG — 50% evidence 5.1/20 RS sector -10% · RS bench -7.2% · 1Y -15.5%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 20.3 + 13.6 + 5.1 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Infosys LtdINFY 56.1/100Mixed-positive evidence82% evidence BASING 18.2/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence 20.0/25 ROCE 40% · OPM 24% 76% evidence 14.1/20 P/E 14.7× · PEG — 50% evidence 3.8/20 RS sector -21.2% · RS bench -18.8% · 1Y -25.4%0 of 12 weeks ahead 100% evidence
Exact sum: 18.2 + 20 + 14.1 + 3.8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Xchanging Solutions LtdXCHANGING 55.0/100Mixed-positive evidence77% evidence ASLEEP 21.0/35 Revenue 9.7% · PAT 18% · OPM change 3 pp 83% evidence 15.3/25 ROCE 18% · OPM 37% 95% evidence 13.4/20 P/E 12.4× · PEG — 50% evidence 5.3/20 RS sector -24.4% · RS bench -11.9% · 1Y -27.2%1 of 10 weeks ahead 70% evidence
Exact sum: 21 + 15.3 + 13.4 + 5.3 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21RNIT AI Solutions LtdAUTOPALIND 54.4/100Thin evidence · provisional51% evidence 20.5/35 Revenue 59.8% · PAT 66.7% · OPM change 5.1 pp 83% evidence 14.6/25 ROCE 20.2% · OPM 40.2% 76% evidence 9.3/20 P/E 39.8× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —5 of 10 weeks ahead 0% evidence
Exact sum: 20.5 + 14.6 + 9.3 + 10 = 54.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Dynacons Systems & Solutions LtdDSSL 53.7/100Mixed-positive evidence83% evidence LEADER 15.7/35 Revenue 12.4% · PAT 19.4% · OPM change 0 pp 83% evidence 16.8/25 ROCE 29.8% · OPM 9% 95% evidence 7.8/20 P/E 18.5× · PEG — 50% evidence 13.4/20 RS sector 10.4% · RS bench 14.3% · 1Y 19.9%12 of 12 weeks ahead 100% evidence
Exact sum: 15.7 + 16.8 + 7.8 + 13.4 = 53.7 · Decision use: Price leads the evidence: RS versus the benchmark is 14.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
23HCL Technologies LtdHCLTECH 53.5/100Mixed-positive evidence76% evidence TURNING 12.6/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence 19.0/25 ROCE 30.4% · OPM 20% 76% evidence 9.5/20 P/E 20.2× · PEG — 50% evidence 12.4/20 RS sector 9.9% · RS bench -6.4% · 1Y -9.6%1 of 10 weeks ahead 70% evidence
Exact sum: 12.6 + 19 + 9.5 + 12.4 = 53.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Tanla Platforms LtdTANLA 53.2/100Mixed-positive evidence94% evidence TURNING 14.4/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence 16.4/25 ROCE 26.3% · OPM 16% 100% evidence 13.1/20 P/E 14.6× · PEG 1.21 100% evidence 9.3/20 RS sector -12% · RS bench 5.2% · 1Y -9.6%10 of 10 weeks ahead 70% evidence
Exact sum: 14.4 + 16.4 + 13.1 + 9.3 = 53.2 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
25AvenuesAI LtdCCAVENUE 52.8/100Mixed-positive evidence83% evidence TURNING 20.5/35 Revenue 100% · PAT 25.5% · OPM change -2.3 pp 88% evidence 8.2/25 ROCE 7.7% · OPM 3.7% 100% evidence 14.9/20 P/E 19.6× · PEG 0.37 65% evidence 9.2/20 RS sector -2.2% · RS bench -3.6% · 1Y -1.2%5 of 11 weeks ahead 70% evidence
Exact sum: 20.5 + 8.2 + 14.9 + 9.2 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Seshaasai Technologies LtdSTYL 52.8/100Mixed-positive evidence73% evidence TURNING 13.1/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence 16.9/25 ROCE 27.7% · OPM 23% 100% evidence 12.8/20 P/E 21.2× · PEG 0.81 65% evidence 10.0/20 RS sector — · RS bench — · 1Y —8 of 10 weeks ahead 0% evidence
Exact sum: 13.1 + 16.9 + 12.8 + 10 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Tata Consultancy Services LtdTCS 52.5/100Mixed-positive evidence94% evidence ASLEEP 11.1/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence 22.3/25 ROCE 63% · OPM 26% 100% evidence 11.8/20 P/E 15.9× · PEG 1.85 100% evidence 7.3/20 RS sector -4.6% · RS bench -15.1% · 1Y -24.6%0 of 10 weeks ahead 70% evidence
Exact sum: 11.1 + 22.3 + 11.8 + 7.3 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Expleo Solutions LtdEXPLEOSOL 51.4/100Mixed-positive evidence77% evidence ASLEEP 15.4/35 Revenue 8.1% · PAT 20.4% · OPM change -1 pp 83% evidence 15.7/25 ROCE 24.8% · OPM 15% 95% evidence 13.9/20 P/E 9.2× · PEG — 50% evidence 6.4/20 RS sector -13.4% · RS bench -13.1% · 1Y -34.3%5 of 10 weeks ahead 70% evidence
Exact sum: 15.4 + 15.7 + 13.9 + 6.4 = 51.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
29IZMO LtdIZMO 51.2/100Mixed-positive evidence77% evidence TURNING 16.2/35 Revenue 26.1% · PAT -2% · OPM change -5 pp 83% evidence 12.5/25 ROCE 12.6% · OPM 14% 95% evidence 6.6/20 P/E 31.2× · PEG — 50% evidence 15.9/20 RS sector 28.9% · RS bench 19.5% · 1Y 161%7 of 10 weeks ahead 70% evidence
Exact sum: 16.2 + 12.5 + 6.6 + 15.9 = 51.2 · Decision use: Price leads the evidence: RS versus the benchmark is 19.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
30LTM LtdLTM 50.8/100Mixed-positive evidence100% evidence TURNING 17.1/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence 17.8/25 ROCE 29.6% · OPM 18% 100% evidence 11.2/20 P/E 23.1× · PEG 1.18 100% evidence 4.7/20 RS sector -16% · RS bench -13.6% · 1Y -14.4%0 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 17.8 + 11.2 + 4.7 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
31Wipro LtdWIPRO 50.3/100Mixed-positive evidence94% evidence ASLEEP 13.8/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence 14.9/25 ROCE 17.8% · OPM 19% 100% evidence 13.2/20 P/E 13.8× · PEG 1.4 100% evidence 8.4/20 RS sector -1.9% · RS bench -18.5% · 1Y -29.1%0 of 10 weeks ahead 70% evidence
Exact sum: 13.8 + 14.9 + 13.2 + 8.4 = 50.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
32Mastek LtdMASTEK 50.3/100Mixed-positive evidence82% evidence TURNING 14.1/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence 13.8/25 ROCE 18% · OPM 15% 76% evidence 12.7/20 P/E 13.2× · PEG — 50% evidence 9.7/20 RS sector -6.7% · RS bench -4.4% · 1Y -24.4%1 of 12 weeks ahead 100% evidence
Exact sum: 14.1 + 13.8 + 12.7 + 9.7 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
33Subex LtdSUBEXLTD 50.0/100Thin evidence · provisional53% evidence TURNING 19.8/35 Revenue -2.3% · PAT 100% · OPM change 31 pp 62% evidence 8.7/25 ROCE 12.8% · OPM 12.6% 95% evidence 9.9/20 P/E 21.7× · PEG — 15% evidence 11.6/20 RS sector — · RS bench 8.4% · 1Y —3 of 3 weeks ahead 25% evidence
Exact sum: 19.8 + 8.7 + 9.9 + 11.6 = 50 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Birlasoft LtdBSOFT 49.4/100Mixed-negative evidence100% evidence BASING 19.8/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence 13.0/25 ROCE 21.2% · OPM 16% 100% evidence 14.5/20 P/E 14.2× · PEG 0.62 100% evidence 2.1/20 RS sector -21.6% · RS bench -19% · 1Y -23.5%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 13 + 14.5 + 2.1 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
35Blue Cloud Softech Solutions Ltd539607 49.1/100Mixed-negative evidence65% evidence TURNING 20.3/35 Revenue 25.7% · PAT 39.5% · OPM change 8 pp 83% evidence 10.7/25 ROCE 14.2% · OPM 17% 76% evidence 9.6/20 P/E 29.8× · PEG — 15% evidence 8.5/20 RS sector -1.9% · RS bench -14.9% · 1Y -35.1%0 of 10 weeks ahead 70% evidence
Exact sum: 20.3 + 10.7 + 9.6 + 8.5 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
36Hexaware Technologies LtdHEXT 48.3/100Mixed-negative evidence94% evidence TURNING 14.5/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence 17.5/25 ROCE 30.1% · OPM 16% 100% evidence 10.4/20 P/E 24.2× · PEG 0.81 100% evidence 5.9/20 RS sector -21.4% · RS bench -9.9% · 1Y -24%6 of 10 weeks ahead 70% evidence
Exact sum: 14.5 + 17.5 + 10.4 + 5.9 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
37Mphasis LtdMPHASIS 48.1/100Mixed-negative evidence94% evidence TURNING 15.3/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence 17.1/25 ROCE 22.1% · OPM 18% 100% evidence 5.6/20 P/E 23.1× · PEG 2.19 100% evidence 10.1/20 RS sector 0% · RS bench -9.2% · 1Y -10.8%0 of 10 weeks ahead 70% evidence
Exact sum: 15.3 + 17.1 + 5.6 + 10.1 = 48.1 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
38Zensar Technologies LtdZENSARTECH 47.4/100Mixed-negative evidence100% evidence BASING 15.8/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence 13.8/25 ROCE 22.8% · OPM 15% 100% evidence 13.3/20 P/E 14.5× · PEG 1.11 100% evidence 4.5/20 RS sector -23.7% · RS bench -21.9% · 1Y -36.2%0 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 13.8 + 13.3 + 4.5 = 47.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
39TechNVision Ventures LtdTECHNVISN 46.5/100Mixed-negative evidence62% evidence ASLEEP 17.0/35 Revenue 18.2% · PAT 90.9% · OPM change -5.7 pp 62% evidence 8.9/25 ROCE 12.9% · OPM -4.1% 95% evidence 8.5/20 P/E 12760× · PEG — 15% evidence 12.1/20 RS sector 32.1% · RS bench -21.9% · 1Y 16.2%0 of 7 weeks ahead 70% evidence
Exact sum: 17 + 8.9 + 8.5 + 12.1 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
40XT Global Infotech LtdXTGLOBAL 46.5/100Mixed-negative evidence61% evidence 18.7/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence 9.2/25 ROCE 7.5% · OPM 9.5% 71% evidence 9.4/20 P/E 40.8× · PEG — 50% evidence 9.2/20 RS sector -1.1% · RS bench -12.7% · 1Y -18.7%2 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 18.7 + 9.2 + 9.4 + 9.2 = 46.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
41Unicommerce eSolutions LtdUNIECOM 46.4/100Mixed-negative evidence70% evidence ASLEEP 14.9/35 Revenue 51.6% · PAT 16.1% · OPM change -4.8 pp 83% evidence 17.1/25 ROCE 21.1% · OPM 13.4% 95% evidence 9.1/20 P/E 46.5× · PEG — 15% evidence 5.3/20 RS sector -14.5% · RS bench -24.2% · 1Y -31.1%0 of 10 weeks ahead 70% evidence
Exact sum: 14.9 + 17.1 + 9.1 + 5.3 = 46.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
42Capillary Technologies India LtdCAPILLARY 44.2/100Thin evidence · provisional59% evidence ASLEEP 21.6/35 Revenue 22.5% · PAT 271.4% · OPM change -2 pp 88% evidence 4.0/25 ROCE 3.6% · OPM 16% 100% evidence 8.6/20 P/E 134× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence
Exact sum: 21.6 + 4 + 8.6 + 10 = 44.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
43Magellanic Cloud LtdMCLOUD 44.0/100Mixed-negative evidence77% evidence TURNING 13.3/35 Revenue 17.1% · PAT 11.7% · OPM change -3 pp 83% evidence 15.4/25 ROCE 19.8% · OPM 26% 95% evidence 11.9/20 P/E 14.9× · PEG — 50% evidence 3.4/20 RS sector -54.5% · RS bench -27.4% · 1Y -64.9%5 of 11 weeks ahead 70% evidence
Exact sum: 13.3 + 15.4 + 11.9 + 3.4 = 44 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
44Mindteck (India) LtdMINDTECK 43.8/100Mixed-negative evidence77% evidence ASLEEP 14.6/35 Revenue -4% · PAT 10.3% · OPM change 2 pp 83% evidence 10.6/25 ROCE 15.1% · OPM 10% 95% evidence 11.7/20 P/E 18.2× · PEG — 50% evidence 6.9/20 RS sector -10.1% · RS bench -9.9% · 1Y -6.9%3 of 10 weeks ahead 70% evidence
Exact sum: 14.6 + 10.6 + 11.7 + 6.9 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
45Innovana Thinklabs LtdINNOVANA 38.7/100Mixed-negative evidence77% evidence ASLEEP 10.2/35 Revenue 27.9% · PAT -18.2% · OPM change -46.5 pp 83% evidence 10.0/25 ROCE 16.4% · OPM 9.7% 95% evidence 9.7/20 P/E 17.8× · PEG — 50% evidence 8.8/20 RS sector -0.4% · RS bench -22% · 1Y -39.3%0 of 10 weeks ahead 70% evidence
Exact sum: 10.2 + 10 + 9.7 + 8.8 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4663 Moons Technologies Ltd63MOONS 38.7/100Mixed-negative evidence62% evidence TURNING 16.7/35 Revenue 100% · PAT -17% · OPM change 397 pp 83% evidence 3.4/25 ROCE -3.7% · OPM -57% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.6/20 RS sector -22.4% · RS bench 26.5% · 1Y -10.7%7 of 11 weeks ahead 70% evidence
Exact sum: 16.7 + 3.4 + 10 + 8.6 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
47Allied Digital Services LtdADSL 38.2/100Mixed-negative evidence62% evidence ASLEEP 18.1/35 Revenue 19.9% · PAT 25.8% · OPM change 0.8 pp 62% evidence 5.5/25 ROCE 7.3% · OPM -3.8% 95% evidence 10.4/20 P/E 18.1× · PEG — 15% evidence 4.2/20 RS sector -29.8% · RS bench -19.6% · 1Y -33.4%5 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 5.5 + 10.4 + 4.2 = 38.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
48Kellton Tech Solutions LtdKELLTONTEC 36.4/100Mixed-negative evidence81% evidence ASLEEP 10.4/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence 9.5/25 ROCE 15% · OPM 11% 95% evidence 11.5/20 P/E 8.3× · PEG — 50% evidence 5.0/20 RS sector -18.8% · RS bench -25.3% · 1Y -55.9%0 of 10 weeks ahead 70% evidence
Exact sum: 10.4 + 9.5 + 11.5 + 5 = 36.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
49Aurionpro Solutions LtdAURIONPRO 35.9/100Mixed-negative evidence93% evidence ASLEEP 13.5/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence 10.7/25 ROCE 16.3% · OPM 17% 100% evidence 9.9/20 P/E 19.3× · PEG 1.39 65% evidence 1.8/20 RS sector -29.5% · RS bench -27.8% · 1Y -47.5%2 of 12 weeks ahead 100% evidence
Exact sum: 13.5 + 10.7 + 9.9 + 1.8 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
50Moschip Technologies LtdMOSCHIP 30.3/100Adverse evidence87% evidence TURNING 8.1/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence 6.8/25 ROCE 11% · OPM 8.2% 100% evidence 3.7/20 P/E 127× · PEG 5.04 65% evidence 11.7/20 RS sector 1.9% · RS bench -2.2% · 1Y 23.8%9 of 10 weeks ahead 70% evidence
Exact sum: 8.1 + 6.8 + 3.7 + 11.7 = 30.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
51Quick Heal Technologies LtdQUICKHEAL 20.4/100Adverse evidence69% evidence ASLEEP 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence 1.6/25 ROCE -4.7% · OPM -39% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 2.6/20 RS sector -35.1% · RS bench -34% · 1Y -52.5%8 of 12 weeks ahead 100% evidence
Exact sum: 6.2 + 1.6 + 10 + 2.6 = 20.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
52Covance Softsol Ltd544361 66.7/100Thin evidence · provisional49% evidence 25.7/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence 17.9/25 ROCE 31.4% · OPM 23.1% 76% evidence 10.7/20 P/E 15.3× · PEG — 15% evidence 12.4/20 RS sector — · RS bench 82.1% · 1Y — 25% evidence
Exact sum: 25.7 + 17.9 + 10.7 + 12.4 = 66.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
53Meta Infotech LtdMETA 54.6/100Thin evidence · provisional21% evidence 17.1/35 Revenue — · PAT — · OPM change -2 pp 10% evidence 16.3/25 ROCE 51.1% · OPM 8% 57% evidence 11.2/20 P/E 13× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y -52.4%0 of 12 weeks ahead to 2026-03-08 0% evidence
Exact sum: 17.1 + 16.3 + 11.2 + 10 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
54TAC Infosec LtdTAC 54.2/100Thin evidence · provisional50% evidence TURNING 18.1/35 Revenue — · PAT — · OPM change -6 pp 26% evidence 20.5/25 ROCE 38.1% · OPM 45% 95% evidence 9.1/20 P/E 46.4× · PEG — 15% evidence 6.5/20 RS sector -13.2% · RS bench -13.4% · 1Y 12.1%1 of 10 weeks ahead 70% evidence
Exact sum: 18.1 + 20.5 + 9.1 + 6.5 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
55Exato Technologies Ltdthis page544626 52.7/100Thin evidence · provisional33% evidence 17.1/35 Revenue — · PAT — · OPM change -3.9 pp 32% evidence 16.1/25 ROCE 26.8% · OPM 10.4% 76% evidence 9.5/20 P/E 36.6× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.1 + 16.1 + 9.5 + 10 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
56Unified Data- Tech Solutions LtdUNIFIED 52.4/100Thin evidence · provisional22% evidence 15.8/35 Revenue — · PAT — · OPM change -8 pp 15% evidence 16.9/25 ROCE 47.9% · OPM 13% 57% evidence 9.7/20 P/E 23.2× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 9.4%0 of 12 weeks ahead to 2026-03-08 0% evidence
Exact sum: 15.8 + 16.9 + 9.7 + 10 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
57Kody Technolab LtdKODYTECH 52.3/100Thin evidence · provisional48% evidence TURNING 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence 12.8/25 ROCE 16.8% · OPM 29% 95% evidence 8.7/20 P/E 121× · PEG — 15% evidence 15.6/20 RS sector 10.3% · RS bench 66.8% · 1Y 94.4%7 of 10 weeks ahead 70% evidence
Exact sum: 15.2 + 12.8 + 8.7 + 15.6 = 52.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
58Trident Techlabs LtdTECHLABS 46.5/100Thin evidence · provisional40% evidence 16.2/35 Revenue — · PAT — · OPM change -2 pp 15% evidence 16.2/25 ROCE 26.7% · OPM 27% 71% evidence 10.8/20 P/E 14.9× · PEG — 15% evidence 3.3/20 RS sector -50.3% · RS bench -56.5% · 1Y -65.1%0 of 12 weeks ahead to 2026-03-29 70% evidence
Exact sum: 16.2 + 16.2 + 10.8 + 3.3 = 46.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
59Excelsoft Technologies LtdEXCELSOFT 46.3/100Thin evidence · provisional43% evidence ASLEEP 12.8/35 Revenue — · PAT — · OPM change -11 pp 45% evidence 13.3/25 ROCE 13.6% · OPM 30% 95% evidence 10.2/20 P/E 19.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —2 of 10 weeks ahead 0% evidence
Exact sum: 12.8 + 13.3 + 10.2 + 10 = 46.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
60ERP Soft Systems Ltd530909 44.8/100Thin evidence · provisional41% evidence 20.3/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence 8.9/20 P/E 74.9× · PEG — 15% evidence 7.6/20 RS sector — · RS bench -47.6% · 1Y -56.7%0 of 12 weeks ahead to 2026-03-29 25% evidence
Exact sum: 20.3 + 8 + 8.9 + 7.6 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
61Veefin Solutions LtdVEEFIN 43.3/100Thin evidence · provisional33% evidence 17.0/35 Revenue — · PAT — · OPM change -12.4 pp 5% evidence 10.4/25 ROCE 6.8% · OPM 20% 57% evidence 9.3/20 P/E 40.5× · PEG — 15% evidence 6.6/20 RS sector -7.2% · RS bench -18.7% · 1Y -30.3%0 of 12 weeks ahead to 2026-03-08 70% evidence
Exact sum: 17 + 10.4 + 9.3 + 6.6 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
62IDream Film Infrastructure Company Ltd504375 41.0/100Thin evidence · provisional30% evidence 13.5/35 Revenue — · PAT 0% · OPM change — 29% evidence 5.0/25 ROCE -9.2% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 12.5/20 RS sector — · RS bench 144.4% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 13.5 + 5 + 10 + 12.5 = 41 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
63Orient Technologies LtdORIENTTECH 33.7/100Thin evidence · provisional45% evidence ASLEEP 15.6/35 Revenue — · PAT — · OPM change -5 pp 13% evidence 2.2/25 ROCE 8.4% · OPM 2.4% 95% evidence 9.0/20 P/E 47.7× · PEG — 15% evidence 6.9/20 RS sector -7.1% · RS bench -16.1% · 1Y -11.7%0 of 10 weeks ahead 70% evidence
Exact sum: 15.6 + 2.2 + 9 + 6.9 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Exato Technologies Ltd's share price today?

Exato Technologies Ltd trades at ₹586. The company is valued at ₹589 Cr. The stock sits at 100% of its 52-week range of ₹354–₹586, +54.9% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 33 weeks in. — as of 31 July 2026.

What were Exato Technologies Ltd's latest quarterly results?

Exato Technologies Ltd reported revenue of ₹61.1 Cr and net profit of ₹4.2 Cr for the Mar 26 quarter. Revenue rose 4.0% and profit fell 24.2% year on year. Earnings per share were ₹4.21. The operating margin was 10.4%, 3.9 pp lower than a year earlier. — as of 31 July 2026.

What is Exato Technologies Ltd's revenue?

Exato Technologies Ltd reported revenue of ₹61.1 Cr in the Mar 26 quarter, +4.0% year on year. For the full FY26 fiscal year, revenue was ₹168 Cr (+35.5%). Over the last 3 years revenue compounded at 32.0% a year. — as of 31 July 2026.

What is Exato Technologies Ltd's profit?

Exato Technologies Ltd earned ₹4.2 Cr of net profit in the Mar 26 quarter, −24.2% year on year. Full-year FY26 profit was ₹16.0 Cr. The operating margin ran 10.4% in the latest quarter. — as of 31 July 2026.

What is Exato Technologies Ltd's market cap?

Exato Technologies Ltd's market capitalisation is ₹589 Cr at a share price of ₹586. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.

What is Exato Technologies Ltd's P/E ratio?

Exato Technologies Ltd trades at a P/E of 36.6×, at the 98th percentile of its own 1-year range, against a long-run median of 0.1×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.

Does Exato Technologies Ltd pay a dividend?

No — Exato Technologies Ltd has recorded a dividend payout of 0% of profit in each of its last 4 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.

Is Exato Technologies Ltd overvalued?

On its own history, Exato Technologies Ltd looks expensive against its own history: its P/E of 36.6× sits at the 98th percentile of its 1-year range (long-run median 0.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.

Is Exato Technologies Ltd growing?

Not right now — Exato Technologies Ltd's latest numbers are shrinking: latest-quarter revenue +4.0% year on year, profit −24.2%, and the margin −3.9 pp at 10.4%. The 3-year compound rates are 32.0% (revenue) and 47.4% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.

How is Exato Technologies Ltd performing?

Exato Technologies Ltd is in a confirmed uptrend, 33 weeks in. Its latest quarter's revenue rose 4.0% and profit fell 24.2% year on year. This describes what the data did, not a rating. — as of 31 July 2026.

Is Exato Technologies Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 33 of stage 2), trading +54.9% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.

Will Exato Technologies Ltd's share price go up?

This page publishes no price forecast for Exato Technologies Ltd. What it measures instead: the share price is ₹586, the price is in a confirmed uptrend 33 weeks in. Its P/E of 36.6× sits at the 98th percentile of its own 1-year range. — as of 31 July 2026.

Who owns Exato Technologies Ltd?

Promoters hold 54.7% of Exato Technologies Ltd, foreign institutions 0.0%, domestic institutions 7.9% and the public 37.4% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.

Does Exato Technologies Ltd have too much debt?

No — Exato Technologies Ltd's debt-to-equity is 0.24, and operating profit covers the interest bill 12×. FY26 borrowings were ₹21.0 Cr against equity of ₹88.0 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.

What is Exato Technologies Ltd's capex?

Exato Technologies Ltd spent ₹32.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹13.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.

What is Exato Technologies Ltd's cash flow?

Exato Technologies Ltd generated ₹2.0 Cr of operating cash flow in FY26 and ₹−11.0 Cr of free cash flow after ₹13.0 Cr of capital spending. Reported profit that year was ₹16.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.

Is Exato Technologies Ltd's profit real cash?

Not fully — over the last 3 fiscal years, 3% of Exato Technologies Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹2.0 Cr against reported profit of ₹16.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.

Where is Exato Technologies Ltd in its business cycle?

Exato Technologies Ltd's FY26 operating margin was 14.0%, against a 4-year band of 7.0%–14.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 10.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.

What could break the Exato Technologies Ltd story?

Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.

Is Exato Technologies Ltd a stock worth studying right now?

This is not investment advice. The machine read: Exato Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI